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Abstract
Physiological or non-physiological factors may affect the vaginal ﬂora. The occurrence of genital microorganisms in non-pregnant females
of all ages was studied, as were the risk factors associated with each microorganism. A retrospective analysis of vaginal and endocervical
cultures and wet smears from 27 172 non-pregnant women, between 1996 to 2005, was performed taking into consideration clinical
and socio-demographic characteristics. No microorganisms were observed in 55.7% of the individuals studied and 44.3% had positive
cultures. There was no microbiological aetiology in 49% of women with genital symptoms. Poor hygiene, chemical irritants, sexual
behaviour, vaginal blood, birth control type, and/or the lack of an oestrogen effect may have caused the symptoms. The highest occur-
rence of Gram-negative bacteria (p <0.01), mainly Escherichia coli, was observed in prepubescent girls. The highest occurrence of Candida
species (p <0.01) was in women of childbearing age, and of Gram-positive bacteria (p <0.01) in menopausal women. Adolescents, partic-
ularly asymptomatic girls, carried more frequently Ureaplasma urealyticum and Chlamydia trachomatis (p <0.01). Hormonal contraception
and consistent condom use was protective against bacterial vaginosis and U. urealyticum colonization. Users of intrauterine devices had
an increased risk of bacterial vaginosis or of contracting U. urealyticum, Mycoplasma hominis and Candida species. Genital complaints were
an independent indicator of Candida species, Gram-negative and Gram-positive bacteria, Trichomonas vaginalis and bacterial vaginosis.
Chlamydia trachomatis infections were often asymptomatic. It is concluded that the hormonal milieu and non-physiological factors are
major determinants of the vaginal ﬂora. If diagnosis of genital infections is based on symptoms alone and not on culture results, it may
be erroneous. Sexual abuse should be investigated when a child presents with a sexually transmitted disease.
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Introduction
Genital tract infections are one of the most common rea-
sons why women seek gynaecological advice. In the last few
decades an increase in these infections, as in sexually trans-
mitted diseases (STDs), has been observed [1]. A physiologi-
cal microﬂora of the genital tract may protect against genital
infectious diseases and/or the transmission of STDs. A non-
physiological vaginal microﬂora is associated with several
gynaecological problems such as adverse pregnancy out-
comes, postpartum endometritis, post-surgical infections
and/or pelvic inﬂammatory diseases [2–4].
The vaginal ﬂora is highly dynamic with a local microbial
system. The equilibrium therein may be disturbed by physio-
logical or non-physiological changes, mediated by the hor-
monal status, sexual behaviour, vaginal blood, foreign bodies
and/or concurrent use of medications.
Although some studies have investigated risk factors asso-
ciated with, and/or the effects of the hormonal milieu on,
some speciﬁc genital microorganisms, to the best of our
knowledge there are no recent studies that have analysed the
frequency of a wide spectrum of genital microorganisms in a
large female population. The objectives of this study were to
evaluate the occurrence of genital microorganisms in a large
population of non-pregnant females of all ages and to identify
the risk factors associated with each microorganism.
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Methods
Study population
Non-pregnant females at ﬁrst visit in the outpatient clinic for
Genital Tract Diseases from 1996 to 2005 were enrolled in
this study. Tests were made in cases of genital complaints, as
part of routine investigation into infertility, before invasive
procedures, i.e. insertion of intrauterine devices (IUDs),
hysteroscopy, transvaginal sonosalpingography, or when a
Pap-test was positive for inﬂammation.
Data collection
Data concerning the microbiological tests and the socio-
demographic/clinical characteristics of the women for whom
cervico-vaginal smears were performed were retrospectively
collected from computerized microbiology laboratory
archives. The socio-demographic/clinical data included: age,
ethnic group, education, marital status, sexual history, type
of contraception, obstetrical history, and reason for giving
the test. Age was categorized as £13, 14–25, 26–35, 36–45,
46–55, 56–65, ‡66 years. The ﬁrst group included children
who were presumed not to have had sexual intercourse and
the last included women who had not had natural menses
for at least 10 years before the tests. A sub-analysis of ado-
lescents (14–19 years), generally considered at high risk of
STDs [1], was carried out.
The cohort was divided into two categories, according to
the presence (symptomatic), or absence (asymptomatic), of
clear symptoms of lower genital tract infections (vaginal dis-
charge, vulvar or vaginal complaints). At the time of visit,
speciﬁc microbiological tests had already been performed in
all patients, motivated by the patient’s history and physical
examination.
Our study group included females in three different hor-
monal states: premenarche (young girls who had not yet had
their ﬁrst menses); childbearing age (non-pregnant women
after menarche and before menopause); menopause (absence
of natural menses for at least 1 year).
Microbiological tests
All patients were tested with the same methods: vaginal
swabs were taken to evaluate the presence of bacterial vagi-
nosis (BV), Candida species, Trichomonas vaginalis, and/or
Gram-positive/negative organisms. Endocervical samples were
used to evaluate the presence of Chlamydia trachomatis,
Ureaplasma urealyticum and/or Mycoplasma hominis.
Vaginal smears, collected from the posterior fornix, were
analysed by microscopy at 40· magniﬁcation to identify T. vag-
inalis and Candida spp. Another vaginal swab was placed in
transport media and cultured by standard laboratory meth-
ods for Candida spp. and Gram-negative/positive bacteria,
and then Gram-stained. Candida spp. were isolated by selec-
tive culture on CHROMagar (Becton Dickinson) at +37C
for 48 h and identiﬁed on the appearance of green colonies.
The diagnosis of BV was based on three out of four of
Amsel’s criteria [5]. Genital mycoplasmas were diagnosed
using Mycofast Evolution 3 broth culture (International
Microbio–D.I.D.). The culture was considered positive at
>103 unit change colour. Chlamydia trachomatis was detected
using Transcription Mediated Ampliﬁcation (TMA) with a
DNA probe dedicated to detect ribosomal RNA gene ampli-
cons of C. trachomatis in endocervical samples (Gen-Probe
AMP CT TMA test for Chlamydia, bioMe´rieux)
Statistical methods
Categorical data were compared using either chi-square or
Fisher’s exact tests. Univariate analyses were performed sep-
arately for each of the risk factor variables, to ascertain the
crude odds ratios (ORC) and the 95% CIs (ORC), estimated
by logistic analysis.
A calculation of the adjusted OR (ORA) and 95% CI
(ORA) was made using multiple logistic regression models, to
identify any variables that were independently associated
with each single microorganism. Where data were incom-
plete, the cases were eliminated from the logistic regression
models. A p-value of <0.05 was considered statistically signif-
icant. Statistical analyses were performed using the SPSS 15.0
software package (SPSS Inc., Chicago, IL, USA).
Results
A total of 27 172 females were evaluated; their characteris-
tics are shown in Table 1. A positive test result was
observed in 12 040 (44.3%): in 9463 (78.6%) a single micro-
organism was isolated and 2577 (21.4%) had polymicrobial
colonization. Candida spp. were isolated in 4904/27 127
(18.1%) females, U. urealyticum in 3814/22 591 (16.9%),
Gram-positive bacteria in 1778/19 508 (9.1%) and Gram-neg-
ative bacteria in 1450/19 508 (7.4%), M. hominis in 385/
22 591 (1.7%), T. vaginalis in 382/24 300 (1.6%) and C. tracho-
matis in 321/23 009 (1.4%); BV occurred in 2135/24 122
(8.9%), The frequency of microorganisms stratiﬁed by age is
shown in Fig. 1.
A total of 14 815 (54.5%) subjects complained of genital
symptoms, among whom a single microorganism was isolated
in 5754 (38.8%) and polymicrobial colonization was observed
in 1771 (11.9%). No microorganism was observed in 7290
(49.2%) cases. Among 12 357 (45.5%) asymptomatic subjects
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a single microorganism was isolated in 3666 (30%) cases,
polymicrobial colonization was observed in 790 (6.4%) and
no microorganism in 7901 (63.9%) cases.
Table 2 shows the occurrence of single microorganisms
isolated in the symptomatic and asymptomatic females in dif-
ferent periods of their life. All prepubescent girls reported
symptoms and had the highest occurrence of Gram-negative
bacteria (20.4%, p <0.01). A total of 51.8% of the subjects of
child-bearing age were symptomatic, with the highest
frequency of Candida spp. (20.5%, p <0.05), and 60.4% of
symptomatic menopausal women had the highest occurrence
of Gram-positive bacteria (14.8%, p <0.01) and T. vaginalis
(2.6%, p <0.01).
The sub-analysis of adolescents (data not shown in
Table 2) showed that the asymptomatic adolescents had a
signiﬁcantly higher frequency (p <0.01) of U. urealyticum
(23.5%) and C. trachomatis (6%) compared with the older
fertile women.
Univariate and multivariate analyses of some risk factors
associated with single microorganisms are shown in Table 3.
The multivariate model showed that candidiasis was posi-
tively associated (p <0.05) with being 14–25 years old, being
of Central/West African origin, having 9–13 years of educa-
tion, not having a steady partner, having symptoms and with
current IUD use; it was inversely associated (p <0.01) with
menopause. Gram-negative bacteria were signiﬁcantly associ-
ated (p <0.01) with having genital symptoms; a negative asso-
ciation (p <0.05) was found with hormonal contraception,
age at ﬁrst intercourse between 16–25 years, and South-
American origin. Gram-positive bacteria were signiﬁcantly
associated (p <0.01) with pluriparity, inconsistent condom or
spermicide use and genital symptoms; the association with
menopause was of borderline-statistical signiﬁcance. A nega-
tive association (p <0.01) was found with age at ﬁrst inter-
course between 14–25 years, being of South-American origin
and aged between 36–45 years. Mycoplasma hominis was sig-
niﬁcantly associated (p <0.05) with not having a steady part-
ner and current use of IUD. BV was signiﬁcantly associated
(p <0.01) with the age range of 46–55 years, being of East
European or Central/West African origin, having 0–8 years
of education, not having a steady partner, having had more
than one abortion, current use of IUD, age at ﬁrst inter-
course <19 years, more than two lifetime partners, and with
genital symptoms. A negative association (p <0.05) was found
in individuals without sexual partners in the previous
6 months, or those on oral contraception. Ureaplasma urea-
lyticum was signiﬁcantly associated (p <0.05) with the age
range of 14–25 years, being of Central/West African origin,
having 0–8 and 9–13 years of education, not having a steady
partner, having had more than one previous abortion, cur-
rent use of IUD, inconsistent condom or spermicide use,
more than one partner in the previous 6 months, more than
two lifetime partners. The positive association with being
adolescent was of borderline-statistical signiﬁcance. A nega-
tive association (p <0.05) was found for the use of condom
and hormonal contraception. Chlamydia trachomatis was posi-
tively associated (p <0.05) with the age ranges of 14–36 and
46–55 years, being of South-American or Asian origin, not
TABLE 1. Characteristics of the women (n = 27 172) included
in the study
n %
Age (years) (27 172)
£13 51 0.2
14–25 4129 15.2
26–35 12 589 46.4
36–45 6686 24.6
46–55 2444 9.0
56–65 912 3.3
‡66 316 1.3
Country of origin (26 296)
Italy 24 231 92.2
Foreigner 2065 7.8
West Europe 466 1.7
East Europe 437 1.6
South America 378 1.4
North Africa 393 1.5
Central West Africa 283 1.1
Asia 108 0.4
Education (years) (25 780)
0–8 10 752 42.7
9–13 11 953 46.4
>13 2817 10.9
Marital status (26 043)
Steady partner 17 706 68.0
No steady partner 8337 32.0
Parity (26 422)
Nulliparity 16 342 61.8
Pluriparity 10 080 38.2
Past Preterm labour 164 1.9
Past miscarriage 3554 14.5
‡3 182 5.1
Past Abortion/s
1 3146 12.8
>1 1128 4.6
Contraception (26 219)
None 17 249 65.8
Always condom 2475 9.4
Sometimes condom/spermicide 1407 5.4
IUD 1104 4.2
Oral contraceptives 3984 15.2
Sexual history
Age at ﬁrst intercourse (years) (24 659)
£13 223 0.9
14–15 1769 7.2
16–19 13 471 54.8
‡20 9134 37.1
No. of lifetime partners (24 368)
1 11 169 45.9
2–5 10 783 44.4
6–10 1916 7.9
>10 438 1.8
No. of partners in previous 6 months (24 903)
0 983 4.0
1 23 299 93.8
>1 560 2.2
Hormonal state
Prepuberty 49 0.2
Childbearing age 24 720 91.0
Menopause 1908 7.0
The denominators used to calculate percentages vary as data were not available
for all subjects for all the variables.
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having a steady partner, having had more than two lifetime
partners; it was negatively associated (p <0.01) with symp-
toms. The positive association with oral contraception or
being adolescent were of borderline-statistical signiﬁcance.
Trichomonas vaginalis was positively associated (p <0.05) with
the age range of 14–25 years, being of Central/West African
origin, having 0–8 years of education, having 2–10 lifetime
partners and having genital symptoms.
Discussion
This study analyses a wide spectrum of genital microorgan-
isms in a large female population in the age range between
£13 and ‡66 years. Most individuals were Italian, had a low-
to medium-level education, a steady partner and a reported
low-risk sexual behaviour, and more than half of them used
TABLE 2. Positivity for single microorganisms in symptomatic and asymptomatic females according to their hormonal status
Hormonal state
Prepuberty Childbearing age Menopause
Symptomatic Symptomatic Asymptomatic Symptomatic Asymptomatic
n % n % n % n % n %
Candida spp. 3/49 6.1 2436/11 877 20.5b 1298/10 836 12.0d 97/1088 8.9 47/715 6.6
Gram-positive 2/49 4.1 554/8079 6.9 344/7253 4.7 154/1038 14.8c 47/683 6.9e
Gram-negative 10/49 20.4a 417/8079 5.2 260/7253 3.6 88/1038 8.5 35/683 5.1
M. hominis – – 10/10 104 0.1 5/9694 0.05 1/233 0.1 – –
BV 1/47 2.1 647/10 289 6.3 422/9493 4.4 47/1067 4.4 36/665 5.1
U. urealyticum – – 1110/10 104 10.9 1037/9694 10.7 25/233 10.7 15/164 9.1
C. trachomatis – – 38/10 293 0.4 88/9950 0.9 – – 1/164 0.6
T. vaginalis – – 86/10 421 0.8 27/9861 0.3 27/1032 2.6c 4/666 0.6
The denominators used to calculate percentages vary because not all women were tested for all microorganisms.
aPrepubertal girls had a signiﬁcantly higher frequency of Gram-negative bacteria compared with childbearing and menopausal women (p <0.01).
bSymptomatic childbearing women had a signiﬁcantly higher frequency of Candida spp. compared with symptomatic prepubertal and menopausal females (p <0.05).
cSymptomatic menopausal women had a signiﬁcantly higher frequency of Gram-positive bacteria and T. vaginalis compared with childbearing and prepubertal females
(p <0.01).
dAsymptomatic childbearing women had a signiﬁcantly higher occurrence of Candida spp. compared with asymptomatic menopausal women (p <0.01).
eAsymptomatic menopausal women had a signiﬁcantly higher occurrence of Gram-positive bacteria compared with asymptomatic childbearing women (p <0.05)
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FIG. 1. Frequency of positive cervico-vaginal smears stratiﬁed by age: Candida species presented a peak in the 14–25 years age group. The
occurrence of Gram-positive bacteria increased with age, whereas Gram-negative bacteria showed a peak in children (£13 years). The occur-
rence of bacterial vaginosis and Ureaplasma urealiticum showed two peaks, between 14 and 25 years of age (9.7% and 22%, respectively) and
between 46 and 55 years of age (10.4% and 21%, respectively). Chlamydia trachomatis peaked (2.9%) in patients between 14 and 25 years of age.
The frequency of Trichomonas vaginalis increased with age with a peak in the 56–65 years age group (3.3%). The only cases of T. vaginalis, docu-
mented in the £13 years group, were in two sexually abused children.
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no contraception. We were able to demonstrate a link
between Gram-negative bacteria and prepuberty and
between Gram-positive bacteria and menopause; Candida
spp., BV and U. urealyticum were linked to childbearing age.
The predominant detection of Gram-negative bacteria, par-
ticularly E. coli, in the prepubescent girls can probably be
attributed to poor hygiene and a relatively atrophic vaginal
mucosa and/or neutral pH, which provide an excellent envi-
ronment for growth of enteric bacteria [6,7]. In agreement
with other studies [8–10], we found that candidiasis was
uncommon in prepuberty, probably because of the speciﬁc
endocrine milieu. Trichomoniasis was diagnosed only in two
prepubescent girls who had been sexually abused. We feel
that sexual abuse should always be investigated when a child
presents with STDs.
There was an overall frequency of Candida spp. of 18.1%
at childbearing age; it was the most commonly isolated
microorganism, particularly in adolescents, in agreement
with ﬁndings of other authors [11,12]. Vulvo-vaginal candidi-
asis is an oestrogen-dependent disorder: oestrogens
enhance both Candida adherence to vaginal epithelium and
yeast mycelium formation [12]. Ureaplasma urealyticum, the
second most frequently detected microorganism, was
independently associated with high-risk sexual behaviour.
Literature data concerning this association are contradictory
[13–16]. The occurrence of BV (8.9%) observed in the pres-
ent study was lower than that reported in some studies
from the USA [17], which may be due to an underrepre-
sentation of Central/West African individuals in the popula-
tion studied here.
The percentage of BV cases increased with age within the
childbearing period, as observed by others [18,19], and was
independently associated with high-risk sexual behaviour.
Although the underlying causes of BV are still to be deﬁned,
the relationship between sexual activity and BV has already
been demonstrated [20,21]. The presence of BV may also be
inﬂuenced by the endocrine milieu, as suggested by the 30%
reduction in BV among women using oral contraceptives.
This effect, observed by other authors [7,22,23], can proba-
bly be attributed to the increase in the epithelial cell glyco-
gen content due to the oestrogens, enhancing lactic acid
production and, therefore, lowering the vaginal pH [24]. The
highest rate of C. trachomatis (3.6%) in women of childbearing
age was observed in the subgroup of adolescents and rose
to 6% in asymptomatic subjects. The high risk in adolescents
may be attributable to sexual behavioural attitudes, anatomi-
cal and/or hormonal factors, i.e. an immature cervix, altera-
tions in cervical mucus and/or anovulatory cycles [25].
Gram-positive bacteria were the most frequently isolated
microorganisms in the menopause group, probably due to
the hypoestrogen-related changes of the vaginal environment
(i.e. variations in bioﬁlm formation, thinning of the vaginal
epithelium, changes in quantity, viscosity and glycoprotein
content of the mucus) and to variations in the immune
response [26,27]. Trichomonas vaginalis infection increased
with age, but not with menopause, as observed by others
[28]. This suggests that it is due to sexual behaviour rather
than to hormonal changes. However, in vitro studies [29,30]
suggest that the infectivity of T. vaginalis increases at pH
5.0–6.0 and is inhibited by oestrogens. Women over
66 years had a low BV risk, as reported by others [18,26],
suggesting that the BV frequency does not increase despite
the increase in vaginal pH and despite the fact that lactobacil-
li are replaced by Gram-positive bacteria and coliforms. It
seems plausible that other, not yet deﬁned conditions in the
postmenopausal vaginal environment play an important phys-
iopathogenetic role.
Age was an independent risk factor: individuals
14–25 years of age had a signiﬁcantly higher risk for Candida
spp., U. urealyticum, T. vaginalis and/or C. trachomatis than did
older women, and those over 66 years showed a signiﬁcant
reduction in BV. The association between the age group of
46–55 years and C. trachomatis was an unexpected ﬁnding
and may be related to inaccurate reporting of sexual
behaviour.
Consistent with literature reports [14,17,28,31,32], race
and/or ethnicity were independent risk factors: Central/West
African women had an increased risk of BV, U. urealyticum,
M. hominis, T. vaginalis and Candida spp, East-European
women of BV and Asian and South-American women of
C. trachomatis. Low educational levels were independently
associated with Candida spp., BV, U. urealyticum and T. vaginalis.
Ethnic origin and education were probably associated with
contextual characteristics, i.e. poverty, hygiene and alimen-
tary habits which were not recorded in our database.
In agreement with those of others, our data suggest
that oral contraception has a protective effect against Gram-
negative bacteria and BV [7,22,23] and that it does not
increase the risk of contracting Candida spp. [33,34]. Hor-
monal contraception was not found to be a risk factor for
C. trachomatis. Literature data concerning this association are
contradictory [35–37].
Consistent with data from the literature [12,19,35], there
was a signiﬁcantly higher occurrence of BV, U. urealyticum
and Candida spp. in IUD users, as well as a borderline signif-
icantly increased risk of C. trachomatis and T. vaginalis, per-
haps due to the low occurrence of STDs in the population
studied here. Spermicide and/or inconsistent condom use
were independent risk factors for Gram-positive bacteria
that may be due to changes in the vaginal ﬂora [38]. It was
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observed that the higher the number of lifetime sexual part-
ners, the higher was the risk of acquiring STDs, BV and/or
U. urealyticum.
Although this study is not without limitations (i.e. it is ret-
rospective, complete data were not available concerning
hygiene, alimentary and smoking habits and/or the use of
hormonal replacement therapy; some microorganisms were
not identiﬁed, as selected microbiological tests were per-
formed on the basis of the anamnesis and physical examina-
tion), the cohort was very large. The resulting data
emphasize that hormonal milieu and behavioural attitudes
are the major determinants of vaginal ﬂora.
Our data show that the presence of genital complaints are
a strong indicator of Candida spp., Gram-negative or Gram-
positive bacteria, T. vaginalis and BV. Although all prepubes-
cent girls were symptomatic, 67% had no pathogenic vaginal
microorganisms and only a single pathogenic microorganism
was isolated in the remaining 33%.
This result is consistent with those reported by others
[8,9] and suggests that most genital symptoms may be due
to poor hygiene, chemical irritants and/or the lack of an oes-
trogen effect. In about half of the symptomatic fertile and
menopausal women there was no microbiological aetiology
of the symptoms. Therefore, a presumptive diagnosis of geni-
tal infections, based on symptoms alone, may be erroneous.
Consequently, we are of the opinion that a thorough physical
examination and a detailed anamnesis must be done by spe-
cially trained health personnel. This should include the
recording of all complaints, age, hormonal pattern and sexual
behaviour, and the search for an infectious aetiology in order
to guide the choice of the correct microbiological tests and
of the empiric treatment.
Moreover, the data obtained will guide the set-up of pre-
ventive/informative strategies to maintain vaginal homeostasis
with the aim of reducing the occurrence of genital infections
and STDs.
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